Roche, Securing Genentech, Focuses on Integrating Biotech’s Scientists
Having all but clinched a $46.8 billion deal to acquire the rest of Genentech Inc., Roche Holding AG faces a potentially bigger challenge: How to integrate and squeeze value out of the pioneering California-based biotech firm without killing it.
Article
Roche Acquires innovatis AG to Complement Its Product Portfolio in the Rapidly Growing Area of Cellular Analytics
Roche recently announced that it has signed a definite agreement under which Roche will acquire 100% of innovatis, a provider of automated cell analysis solutions.
Article
The Western Pennsylvania Hospital Joins Prominent Group of Cancer Centers Exploring New Therapy for Leukemia and Lymphoma Patients
The Western Pennsylvania Hospital and the Gamida Cell – Teva Joint Venture announced recently that the hospital is now enrolling patients to participate in the ExCell study.
Article
MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
MultiCell Technologies, Inc. announced recently that it has entered into a cooperative research and development agreement with Maxim Biotech, Inc. to develop products for the study of liver stem cells and liver cancer.
Article
Cenix BioScience Follows Up Successful RNAi-based Target Discovery Screens with Target Validation Study for AstraZeneca.
Cenix BioScience GmbH, a leading RNA interference-focused contract research organization, recently announced that it has initiated a second research project under its existing framework research agreement with AstraZeneca Pharmaceuticals LP, one of the world’s leading pharmaceutical companies.
Article
Battered Miller Group Consoled by 54m Pound Edinburgh Deal as Land bank Writedown Hits Results
The Edinburgh-based company Miller Group will announce that it has won the deal to build the first phase of the £600m Scottish Centre for Regenerative Medicine at the bioquarter being developed in Little France on the outskirts of the city.
Article
Stem Cell Researcher Stemgent Raises $14M
Stemgent Inc. raised a $14 million Series A round this month, just as President Barack Obama has reversed the federal government’s restrictions on embryonic stem cell funding.
Article
San Francisco State, Other Schools Get Stem Cell Grants
California’s stem cell agency has approved $17.5 million in grants to San Francisco State and 10 other state universities to train young scientists in embryonic stem cell technology.
Article
International Stem Cell Corporation Receives Third $1M Tranche under a $5 Million Financing
International Stem Cell Corporation has received the third $1 million tranche of an anticipated private equity financing of up to $5 million to be funded over the next several months.
Article
Stem Cell Therapy International Inc. Announces Bridge Financing Obtained
Stem Cell Therapy International Inc. announced recently that the Company has obtained short term financing, enabling the Company to update and finalize the merger between Stem Cell Therapy International, Inc. and the Histostem Corporation, Ltd.
Article
Rockefeller Receives New $4.8 Million State Grant to Fund Stem Cell Research
Rockefeller University will receive $4.8 million from the state to establish new facilities for studying the molecular basis of how stem cells are maintained and how they differentiate.
Article
NuGEN Introduces WT-Ovation(TM) One-Direct RNA Amplification System For Whole-Transcriptome Expression Analysis From a Single Cell
NuGEN Technologies, Inc announced recently that it has launched the first RNA amplification system enabling whole-transcriptome gene expression analysis from a single cell.
Article
Patent Office Shows Tougher Stance on “Evergreening”
The rate of patent applications refused in Europe has risen to an all time high, as authorities target “evergreening” of intellectual property.
Article